De Novo MYH9-Related Macrothrombocytopenia in a Toddler: Insights From Platelet Mass Index
British Journal of Hospital Medicine · 2026
DOI: 10.31083/bjhm50376 ↗Kurz gefasst
Fallbericht in der Zeitschrift British Journal of Hospital Medicine, 2026. Verfasst von Ioannis Kyriakidis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory …. Hauptthemen laut MEDLINE: Thrombocytopenia, Myosin Heavy Chains, Hearing Loss, Sensorineural, Molecular Motor Proteins. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims/Background: Myosin heavy chain 9-related disease (MYH9-RD) is a rare inherited disorder characterised by macrothrombocytopenia, often misdiagnosed as immune thrombocytopenia (ITP). Early identification is crucial to prevent unnecessary treatments and to ensure appropriate monitoring. The present case aims to highlight the diagnostic challenges and clinical management of MYH9-RD in a toddler, emphasising the importance of early genetic testing. Case Presentation: We discuss a 13.5-month-old girl with macrothrombocytopenia lacking Döhle bodies, who initially received intravenous immunoglobulin (IVIg) and corticosteroids without any response. Within two months, whole-exome sequencing identified a pathogenic MYH9 mutation (c.287C>T; p.Ser96Leu).
Results
One year later, the patient remains clinically stable without significant bleeding. The occurrence of petechial rash exhibited a more pronounced correlation with platelet mass index (PMI) values compared to platelet count (PLT), underscoring its significance in clinical evaluation.
Conclusion
MYH9-RD should be considered in cases of IVIg-resistant thrombocytopenia accompanied by macrothrombocytes. Timely genetic testing can facilitate accurate diagnosis and may help avoid unnecessary procedures, while routine renal and auditory monitoring is important for managing the S96L variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, Un…
Zitieren
APA
Kyriakidis, I., Pelagiadis, I., Stratigaki, M., Katzilakis, N., & Stiakaki, E. (2026). De Novo MYH9-Related Macrothrombocytopenia in a Toddler: Insights From Platelet Mass Index. British Journal of Hospital Medicine. https://doi.org/10.31083/bjhm50376
Vancouver
Kyriakidis I, Pelagiadis I, Stratigaki M, Katzilakis N, Stiakaki E. De Novo MYH9-Related Macrothrombocytopenia in a Toddler: Insights From Platelet Mass Index. British Journal of Hospital Medicine. 2026. doi:10.31083/bjhm50376
BibTeX
@article{Kyriakidis2026,
author = {Kyriakidis, Ioannis and Pelagiadis, Iordanis and Stratigaki, Maria and Katzilakis, Nikolaos and Stiakaki, Eftichia},
title = {De Novo MYH9-Related Macrothrombocytopenia in a Toddler: Insights From Platelet Mass Index},
journal = {British Journal of Hospital Medicine},
year = {2026},
doi = {10.31083/bjhm50376}
}
EUVIMED